NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,175.00
-225.00 (-6.62%)
Oct 11, 2024, 9:00 AM KST

NGeneBio Revenue

NGeneBio had revenue of 2.03B KRW in the quarter ending June 30, 2024, with 127.98% growth. This brings the company's revenue in the last twelve months to 4.99B, down -16.14% year-over-year. In the year 2023, NGeneBio had annual revenue of 4.35B, down -60.51%.

Revenue (ttm)
4.99B
Revenue Growth
-16.14%
P/S Ratio
8.17
Revenue / Employee
48.91M
Employees
102
Market Cap
40.92B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.35B-6.67B-60.51%
Dec 31, 202211.02B3.85B53.81%
Dec 31, 20217.16B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition